TOP

Information

Jiksak Bioengineering Inc. and Teijin Pharma Ltd. signed a joint research agreement to identify novel drug target genes for neurodegenerative diseases.
Sep 2, 2024
News
Papers related to our organoid technology have been published.
May 22, 2024
News
We have commenced collaborative research and development with Molmir Corporation.
Sep 4, 2023
News
Development of Antibodies for Drug Linked Carrier
～Jiksak and MBL announce the jointly developed antibodies for Drug Linked Carrier～
Jul 25, 2023
News
Jiksak Selected for Tokyo City’s Advanced Medical Devices Acceleration Program
Oct 28, 2021
News
Jiksak and Meiji Enter into a Joint Development Agreement
Aug 17, 2021
News
Jiksak Listed in Forbes Japan (Japanese Only)
Nov 30, 2018
News
Jiksak Selected as IPAS Program Recipient
Aug 30, 2018
News